Table 1

Baseline characteristics, Altis vs Solyx vs TVT Abbrevo.

Characteristics

Altis (n ​= ​63)

Solyx (n ​= ​50)

Abbrevo (n ​= ​119)

p-value for all

Data available Altis/Solyx/Abbrevo

Demographic

Age, y, mean ​± ​SD

55.3 ​± ​11.6

52.2 ​± ​11.7

50.8 ​± ​9.9

0.032

63/50/118

Parity total [median (IQR)]a

2 (2,3)

2 (2,3)

3 (2,3)

0.032

61/49/99

Parity vaginal [median (IQR)]

2 (2,3)

2 (1,3)

3 (2,3)

0.004

61/49/99

BMI, mean ​± ​SD

26.2 ​± ​5.3

26.0 ​± ​4.1

26.1 ​± ​5.1

0.98

56/44/95

Post menopausal status, n (%)

35 (55.6)

21 (45.7)

28 (28.0)

0.001

63/46/100

Previous Hysterectomy, n (%)

9 (14.3)

5 (10.9)

15 (16.7)

0.661

63/46/90

Previous POP surgery, n (%)

3 (4.8)

4 (8.7)

13 (12.5)

0.247

63/46/104

Previous SUI surgery, n (%) (Burch colposuspension n ​= ​5)

5 (7.9)

0 (0)

3 (2.9)

0.087

63/46/103

Total PMHx, n (%)b

17 (27.0)

9 (19.6)

16 (14.8)

0.151

63/46/108

Baseline Functional Outcomes

PGI-S [median (IQR)]a

3 (3,4)

3 (3,4)

3 (2,3)

<0.001

56/42/105

Antimuscarinic use, n (%)

5 (8.3)

7 (14.6)

7 (7.4)

0.357

60/48/95

Urodynamic findings

Detrusor overactivity, n (%)

7 (11.5)

2 (4.1)

7 (6.6)

0.407

61/49/106

MUCP (cm H20), mean ​± ​SD

45.7 ​± ​18.0

43.5 ​± ​19.4

42.2 ​± ​16.3

0.492

55/47/98

ALPP (cm H20), mean ​± ​SD

121.1 ​± ​31.9

119.1 ​± ​34.4

115.3 ​± ​46.4

0.697

48/46/91

Maximum flow rate (ml/sec), mean ​± ​SD

31.9 ​± ​14.2

30.7 ​± ​12.5

26.4 ​± ​10.8

0.014

61/49/101

Post void residual volume (ml), mean ​± ​SD

22.4 ​± ​25.3

24.4 ​± ​26.3

27.8 ​± ​28.2

0.448

61/49/104

POP-Q staging [median (IQR)]a

Ba

−1 (−2, 0)

−1 (−2, 0)

−1 (−2, 0)

0.132

51/47/101

Bp

0 (−2, 0)

−2 (−3, 0)

−1 (−2, 0)

0.056

51/48/98

C

−5 (−6, −4)

−6 (−7, −5)

−6 (−7, −4.75)

0.043

52/46/99

Prolapse surgery

Concomitant POP, n (%)

34 (54.0)

26 (55.3)

61 (51.3)

0.875

63/47/119

VH ​± ​A/P or AP, n (%)

27 (42.9)

23 (50.0)

49 (41.2)

0.588

63/46/119

Anterior/apical mesh, n (%) (Uphold® TVM or ASC)

2 (3.2)

1 (2.2)

2 (1.7)

0.838

63/46/119

Posterior Repair, n (%) (no posterior mesh)

5 (7.9)

2 (4.3)

10 (8.4)

0.75

63/46/119

  • Maximum flow rate: post void residual assessment performed at uroflowmetry prior to consent for continence surgery.

    PGI-S:patient global impression of severity; MUCP: maximum urethral closure pressure; ALPP: abdominal leak point pressure; VH ​± ​A/P or AP: vaginal hysterectomy, vault suspension, anterior ​± ​posterior repair; TVM: transvaginal mesh; ASC: abdominal sacrocolpopexy; POP: Pelvic Organ Prolapse; PMHx: Past Medical History; SUI: stress urinary incontinence, n: number of cases.

  • a Median (interquartile range Q1,Q3).

  • b Medical history of diabetes milletus, cardiovascular, respiratory, neurological, connective tissue disorders.